Omzo review
The banner says $179. The Terms and Conditions — where this seller keeps its actual price list, itemized, six products deep — say the months after the first cost $299. They also say $179 was the old price and $199 is the new one, which is a rise dressed as a markdown. And the $279 the homepage puts on tirzepatide is not in that list anywhere: not as a current price, not as a follow-up, not even as the thing that got crossed out.
then $299/mo ongoing
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Omzo at a glance
- Semaglutide
- $299/mo
- Tirzepatide
- $399/mo
- Coverage
- All 50 states
- Brand-name
- Yes
How we scored Omzo
Each score comes out of Omzo's published pricing, disclosures and oversight, and the six combine into the 51/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
The headline rate obscures a plan requirement or a hidden step-up.
Fair value once you read past any teaser rate or plan structure.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- omzo.com
Verified 18 August 2026, with the figures taken from the Terms and Conditions because that is the only surface carrying a schedule. Compounded semaglutide runs $299 a month after a $199 first month; tirzepatide $399 after $349. Brand-name Ozempic is $1,299 and Zepbound $1,399, the same initial and ongoing, each covering consultation, prescription, medication and shipping. Three things about the advertising. The banner's "starting at $179" is 40% under the standing rate. The Terms call $179 the original price and $199 the current one — a rise written as a markdown. And the tirzepatide figure on the homepage, $279, is absent from the schedule altogether. In its favor, the same document is franker about compounding than most: it states that compounded drugs are not FDA-approved, that the agency does not review them for safety, efficacy or quality, and that no equivalence to an approved drug is claimed. It serves all 50 states, holds a LegitScript seal, names no operating company or compounding pharmacy, and screened clean against the live FDA warning-letter index.
What to expect when you sign up
We walked Omzo's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action stays on omzo.com (https://www.omzo.com/quiz-v2)
- 2The intake responded HTTP 200 when checked on 2026-08-21
- 3Walked to the intake entry only. No personal information was submitted, so nothing past the entry screen is asserted here
What we noticed
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $199 → $299 | Follow-up months — the standing rateThe Terms publish "Follow-Up Consultation - GLP-1 ... Priced at $299", with the first month at $199. ⛔ The homepage advertises "Starting at $179" — a figure the Terms describe as the ORIGINAL price, now superseded by a higher one. |
| Compounded tirzepatide | $349 → $399 | Follow-up months — the standing rate"Follow-Up Consultation - GLP-1 + GIP ... Priced at $399", first month $349. ⛔ The homepage's "Starting at $279" appears nowhere in the schedule at all. |
| Brand semaglutide | $1299 | Ozempic — every month"Priced at $1,299" for both the initial and the follow-up package, described as covering consultation, prescription, medication and shipping. |
| Brand tirzepatide | $1399 | Zepbound — every month"Priced at $1,399", initial and follow-up alike. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Omzo's public disclosures at last review and change often; confirm the current number on Omzo's own site.
What we like
- An itemized schedule exists — six packages, each with an initial and a follow-up price
- Consultation, prescription, medication, shipping and ongoing support are all named as included
- Refreshingly blunt about compounding: not FDA-approved, not reviewed for safety or quality, no equivalence claimed
- Brand-name Ozempic and Zepbound carry published prices, at $1,299 and $1,399
- Serves all 50 states and says it ships nowhere else
- LegitScript certified
The caveats
- ⛔ $179 on the banner against $299 in the schedule — a 40% gap with nothing bridging it
- ⛔ "Originally priced at $179, currently offered at $199" is a price increase written as a discount
- ⛔ The homepage's tirzepatide figure, $279, is absent from the schedule entirely
- The only place the real prices live is a legal page nothing links you to
- No operating company named in any legal page
- The compounding pharmacy is never named
Omzo for mothers: our verdict
The banner says $179. The Terms and Conditions — where this seller keeps its actual price list, itemized, six products deep — say the months after the first cost $299. They also say $179 was the old price and $199 is the new one, which is a rise dressed as a markdown. And the $279 the homepage puts on tirzepatide is not in that list anywhere: not as a current price, not as a follow-up, not even as the thing that got crossed out. The advertised entry is $199, but the standing rate settles near $299/month — so read the headline as a starting offer, not the real monthly cost.
We weigh Omzo the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Omzo actually costs
- Compounded semaglutide — Follow-up months — the standing rate: $199 to start, then $299/mo
- Compounded tirzepatide — Follow-up months — the standing rate: $349 to start, then $399/mo
- Brand-name semaglutide — Ozempic — every month: $1299/mo
- Brand-name tirzepatide — Zepbound — every month: $1399/mo
For context, the typical ongoing price across our roster is around $179/month, so Omzo sits at the premium end.
The medications Omzo prescribes
Omzo prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. It can also route you to FDA-approved brand pens rather than only compounded vials, and those carry the manufacturer's own pregnancy and lactation labeling, which is a cleaner document to take to an OB.
Where Omzo fits — and where it doesn't — for mothers
Worth it if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Give it a miss if…
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence in Omzo's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Omzo is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone who will open the Terms before the checkout, and compare on $299 rather than on the banner.
Alternatives to Omzo
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Omzo
Head-to-head & alternatives
Omzo, answered
- How much does Omzo cost?
- When we last checked, the cheapest ongoing compounded price at Omzo was around $299 a month: $299/mo for semaglutide and $399/mo for tirzepatide. Prices here move quickly — confirm today's all-in number on their own site before signing up.
- Is Omzo safe to use while breastfeeding?
- No GLP-1 has been shown to be safe in pregnancy or while nursing, whether compounded or brand-name, and the labeling advises against it. That applies to Omzo as much as to anyone else. Time it for after weaning, and make the decision with your own clinician.
- Does Omzo offer both semaglutide and tirzepatide?
- Yes — Omzo offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Omzo rank for mothers?
- Omzo takes 51/100 in our Editors' Rating, placing it #184. Six factors chosen for mothers feed that number, and CoreAge Rx is the one at the top of the list — see how they compare.
Pricing, states and verification reflect Omzo's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.